{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T16:10:35Z","timestamp":1787674235308,"version":"build-2784847793"},"reference-count":152,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T00:00:00Z","timestamp":1753056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:p>The discovery of microRNAs (miRNAs) and their pivotal role in gene regulation has opened up new avenues for innovative cancer treatments. Recent years have witnessed extensive research into the intricate mechanisms of miRNAs and their impact on solid tumors. These small non-coding RNA molecules are central to gene regulation and are frequently dysregulated in various cancers, particularly solid tumors. Dysregulation of specific miRNAs can initiate, progress, and metastasize tumors, making them appealing targets in cancer therapy. This article explores recent studies on identifying specific miRNAs associated with solid tumors and their influence on crucial signaling pathways. These findings enable precise targeting of cancer cells, reducing damage to healthy tissues and minimizing side effects commonly associated with conventional cancer treatments. Understanding the complex regulatory networks governed by miRNAs allows researchers and clinicians to develop highly effective, personalized treatment strategies, heralding a new era of tailored cancer medicine. Ongoing research in this field holds immense promise for pioneering targeted therapies that can significantly improve outcomes and the quality of life for individuals battling solid tumors.<\/jats:p>","DOI":"10.3389\/fonc.2025.1570093","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T04:10:18Z","timestamp":1753071018000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":6,"title":["Exploring microRNA targeting as a promising approach for solid tumor treatment"],"prefix":"10.3389","volume":"15","author":[{"given":"Behrouz","family":"Shademan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vahidreza","family":"Karamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alireza","family":"Nourazarian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cigir","family":"Biray Avci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2025,7,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2018.00403","article-title":"Intracytoplasmic re-localization of miRISC complexes","volume":"9","author":"Akg\u00fcl","year":"2018","journal-title":"Front Genet"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1333563","article-title":"Exploring the intricate relationship between miRNA dysregulation and breast cancer development: insights into the impact of environmental chemicals","volume":"15","author":"Abolhasanzadeh","year":"2024","journal-title":"Front Immunol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3390\/ncrna10050052","article-title":"MicroRNA biogenesis, gene regulation mechanisms, and availability in foods","volume":"10","author":"de Mello","year":"2024","journal-title":"Non-coding RNA"},{"key":"B4","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.3390\/diagnostics14131450","article-title":"Synthesis and regulation of miRNA, its role in oncogenesis, and its association with colorectal cancer progression, diagnosis, and prognosis","volume":"14","author":"Rac","year":"2024","journal-title":"Diagnostics"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2009.02.005","article-title":"MicroRNAs and cancer: short RNAs go a long way","volume":"136","author":"Ventura","year":"2009","journal-title":"Cell"},{"key":"B6","doi-asserted-by":"publisher","first-page":"4020","DOI":"10.3390\/jcm9124020","article-title":"The expression paterns of BECN1, LAMP2, and PINK1 genes in colorectal cancer are potentially regu-lated by micrornas and cpG islands: an in silico study","volume":"9","author":"Bednarczyk","year":"2020","journal-title":"J Clin Med"},{"key":"B7","doi-asserted-by":"publisher","first-page":"343","DOI":"10.3390\/biomedicines9040343","article-title":"Involvement of microRNA in solid cancer: role and regulatory mechanisms","volume":"9","author":"Lin","year":"2021","journal-title":"Biomedicines"},{"key":"B8","doi-asserted-by":"publisher","first-page":"13620","DOI":"10.3390\/ijms232113620","article-title":"Regulation of the key epithelial cancer suppressor miR-124 function by competing endogenous RNAs","volume":"23","author":"Braga","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1002\/gcc.20804","article-title":"Epigenetic regulation of miR-196b expression in gastric cancer","volume":"49","author":"Tsai","year":"2010","journal-title":"Genes Chromosomes Cancer"},{"key":"B10","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1007\/978-981-96-4959-4","article-title":"Role of microRNAs in cancer","author":"Rawat","year":"2025","journal-title":"InBiotechnology Cancer Ther"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.3109\/10409238.2015.1117054","article-title":"Dysregulation of microRNA biogenesis machinery in cancer","volume":"51","author":"Hata","year":"2016","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"B12","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.3390\/cancers17091513","article-title":"DICER1 mutational spectrum in intracranial CNS-neoplasias\u2014A review and a report from the CNS-interREST GPOH study center","volume":"17","author":"Manea","year":"2025","journal-title":"Cancers"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1016\/j.molcel.2022.10.010","article-title":"Structural and functional basis of mammalian microRNA biogenesis by Dicer","volume":"82","author":"ZaplEtal","year":"2022","journal-title":"Mol Cell"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.1007\/s10142-022-00909-w","article-title":"CmirC: an integrated database of clustered miRNAs co-localized with copy number variations in cancer","volume":"22","author":"Ware","year":"2022","journal-title":"Funct Integr Genomics"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/j.neo.2021.05.016","article-title":"Copy number variation in triple negative breast cancer samples associated with lymph node metastasis","volume":"23","author":"Pariyar","year":"2021","journal-title":"Neoplasia"},{"key":"B16","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1146\/annurev.pathol.4.110807.092222","article-title":"MicroRNAs in cancer","volume":"4","author":"Lee","year":"2009","journal-title":"Annu Rev Pathology: Mech Disease"},{"key":"B17","article-title":"Global Cancer Statistics 2022: the trends projection analysis","volume":"10","author":"Chhikara","year":"2023","journal-title":"Chem Biol Letters"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2021.628744","article-title":"Availability, affordability, access, and pricing of anti-cancer medicines in low-and middle-income countries: a systematic review of literature","volume":"9","author":"Ocran Mattila","year":"2021","journal-title":"Front Public Health"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21597","article-title":"Enhancing global access to cancer medicines","volume":"70","author":"Cortes","year":"2020","journal-title":"CA: Cancer J Clin"},{"key":"B20","doi-asserted-by":"publisher","first-page":"e000285","DOI":"10.1136\/esmoopen-2017-000285","article-title":"Global cancer control: responding to the growing burden, rising costs and inequalities in access","volume":"3","author":"Prager","year":"2018","journal-title":"ESMO Open"},{"key":"B21","doi-asserted-by":"publisher","first-page":"28","DOI":"10.12927\/hcq.2014.24006","article-title":"Integrating cancer care beyond the hospital and across the cancer pathway: a patient-centred approach 2015","volume":"17","author":"Evans","year":"2015","journal-title":"Healthc Q"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.v117.10s","article-title":"A review of Canadian health care and cancer care systems","volume":"117","author":"Sutcliffe","year":"2011","journal-title":"Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1111\/add.v111.4","article-title":"Advancing patient-centered care for structurally vulnerable drug-using populations: a qualitative study of the perspectives of people who use drugs regarding the potential integration of harm reduction interventions into hospitals","volume":"111","author":"McNeil","year":"2016","journal-title":"Addiction"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1007\/s00520-014-2348-3","article-title":"Research in cancer care disparities in countries with universal healthcare: mapping the field and its conceptual contours","volume":"22","author":"Sinding","year":"2014","journal-title":"Supportive Care Cancer"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1007\/s11060-019-03378-7","article-title":"Socioeconomic factors affect treatment delivery for patients with low grade glioma: a Swedish population-based study","volume":"146","author":"Carstam","year":"2020","journal-title":"J Neuro-oncology"},{"key":"B26","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1186\/s12939-023-01860-3","article-title":"Barriers to cancer treatment and care for people experiencing structural vulnerability: a secondary analysis of ethnographic data","volume":"22","author":"Bourgeois","year":"2023","journal-title":"Int J Equity Health"},{"key":"B27","doi-asserted-by":"publisher","first-page":"107873","DOI":"10.1016\/j.clineuro.2023.107873","article-title":"Relationship between miRNA-21, miRNA-155, and miRNA-182 expression and inflammatory factors in cerebrospinal fluid from patients with multiple sclerosis","volume":"232","author":"Shademan","year":"2023","journal-title":"Clin Neurol Neurosurgery"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.34172\/apb.2023.047","article-title":"MicroRNAs as targets for cancer diagnosis: interests and limitations","volume":"13","author":"Shademan","year":"2022","journal-title":"Advanced Pharm Bull"},{"key":"B29","doi-asserted-by":"publisher","first-page":"521","DOI":"10.1186\/s12859-018-2518-2","article-title":"Identification of pre-microRNAs by characterizing their sequence order evolution information and secondary structure graphs","volume":"19","author":"Ma","year":"2018","journal-title":"BMC Bioinf"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3390\/jcm4081651","article-title":"MicroRNA processing and human cancer","volume":"4","author":"Ohtsuka","year":"2015","journal-title":"J Clin Med"},{"key":"B31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41544-019-0024-y","article-title":"Recent progress in microRNA-based delivery systems for the treatment of human disease","volume":"1","author":"Fu","year":"2019","journal-title":"ExRNA"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M404931200","article-title":"Structural features of microRNA (miRNA) precursors and their relevance to miRNA biogenesis and small interfering RNA\/short hairpin RNA design","volume":"279","author":"Krol","year":"2004","journal-title":"J Biol Chem"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.2174\/2211536611666220928154015","article-title":"MicroRNAs as a new target for Alzheimer\u2019s disease treatment","volume":"12","author":"Shademan","year":"2023","journal-title":"Microrna (Shariqah United Arab Emirates)"},{"key":"B34","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1007\/s13238-012-2003-z","article-title":"Horizontal transfer of microRNAs: molecular mechanisms and clinical applications","volume":"3","author":"Chen","year":"2012","journal-title":"Protein Cell"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1111\/resp.13756","article-title":"Molecular techniques for respiratory diseases: MicroRNA and extracellular vesicles","volume":"25","author":"Gon","year":"2020","journal-title":"Respirology"},{"key":"B36","doi-asserted-by":"publisher","first-page":"101613","DOI":"10.1016\/j.tranon.2022.101613","article-title":"MicroRNAs as clinical tools for diagnosis, prognosis, and therapy in prostate cancer","volume":"28","author":"Ghamlouche","year":"2023","journal-title":"Trans Oncol"},{"key":"B37","doi-asserted-by":"publisher","first-page":"35","DOI":"10.1124\/jpet.121.000896","article-title":"Circulating microRNAs as reliable tumor biomarkers: Opportunities and Challenges facing Clinical Application","volume":"384","author":"El-Daly","year":"2023","journal-title":"J Pharmacol Exp Ther"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1038\/oncsis.2013.21","article-title":"Epigenetic silencing of monoallelically methylated miRNA loci in precancerous colorectal lesions","volume":"2","author":"Menigatti","year":"2013","journal-title":"Oncogenesis"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2019.00626","article-title":"Circulating microRNAs in cancer: potential and challenge","volume":"10","author":"Cui","year":"2019","journal-title":"Front Genet"},{"key":"B40","doi-asserted-by":"publisher","first-page":"153241","DOI":"10.1016\/j.prp.2020.153241","article-title":"Regulatory role of microRNAs in cancer through Hippo signaling pathway","volume":"216","author":"Astamal","year":"2020","journal-title":"Pathology-Research Pract"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1007\/s10555-009-9188-5","article-title":"MicroRNA function in cancer: oncogene or a tumor suppressor","volume":"28","author":"Shenouda","year":"2009","journal-title":"Cancer metastasis Rev"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1093\/carcin\/bgs383","article-title":"MiR-124 targets Slug to regulate epithelial\u2013mesenchymal transition and metastasis of breast cancer","volume":"34","author":"Liang","year":"2013","journal-title":"Carcinogenesis"},{"key":"B43","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.ccell.2015.01.002","article-title":"Mutations in the SIX1\/2 pathway and the DROSHA\/DGCR8 miRNA microprocessor complex underlie high-risk blastemal type Wilms tumors","volume":"27","author":"Wegert","year":"2015","journal-title":"Cancer Cell"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2009.06934.x","article-title":"A study of microRNAs in silico and in vivo: diagnostic and therapeutic applications in cancer","volume":"276","author":"Waldman","year":"2009","journal-title":"FEBS J"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.0404432101","article-title":"MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias","volume":"101","author":"Calin","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0013067","article-title":"Human microRNA oncogenes and tumor suppressors show significantly different biological patterns: from functions to targets","volume":"5","author":"Wang","year":"2010","journal-title":"PloS One"},{"key":"B47","doi-asserted-by":"publisher","first-page":"e39520","DOI":"10.1371\/journal.pone.0039520","article-title":"Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT\/ERK1\/2 inactivation by targeting PTEN","volume":"7","author":"Han","year":"2012","journal-title":"PloS One"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1038\/ncb2024","article-title":"miR-9, a MYC\/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis","volume":"12","author":"Ma","year":"2010","journal-title":"Nat Cell Biol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.1038\/embor.2009.9","article-title":"miR-29a suppresses tristetraprolin, which is a regulator of epithelial polarity and metastasis","volume":"10","author":"Gebeshuber","year":"2009","journal-title":"EMBO Rep"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-12-0832","article-title":"Prospero homeobox 1 promotes epithelial-mesenchymal transition in colon cancer cells by inhibiting E-cadherin via miR-9","volume":"18","author":"Lu","year":"2012","journal-title":"Clin Cancer Res"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-12-0667","article-title":"miR-103\/107 promote metastasis of colorectal cancer by targeting the metastasis suppressors DAPK and KLF4","volume":"72","author":"Chen","year":"2012","journal-title":"Cancer Res"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-006-3486-y","article-title":"Cathepsin-regulated apoptosis","volume":"11","author":"Chwieralski","year":"2006","journal-title":"Apoptosis"},{"key":"B53","doi-asserted-by":"publisher","DOI":"10.1038\/bjc.2011.408","article-title":"The role of Cathepsin S as a marker of prognosis and predictor of chemotherapy benefit in adjuvant CRC: a pilot study","volume":"105","author":"Gormley","year":"2011","journal-title":"Br J Cancer"},{"key":"B54","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M509134200","article-title":"Cathepsin S controls angiogenesis and tumor growth via matrix-derived angiogenic factors","volume":"281","author":"Wang","year":"2006","journal-title":"J Biol Chem"},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1007\/s10495-018-1451-1","article-title":"Dysregulated genes and miRNAs in the apoptosis pathway in colorectal cancer patients","volume":"23","author":"Slattery","year":"2018","journal-title":"Apoptosis"},{"key":"B56","doi-asserted-by":"publisher","first-page":"725","DOI":"10.3390\/biomedicines13030725","article-title":"Epigenetic regulation of chromatin functions by microRNAs and long noncoding RNAs and implications in human diseases","volume":"13","author":"Costa","year":"2025","journal-title":"Biomedicines"},{"key":"B57","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00210-025-04217-5","article-title":"Epigenetic dynamics and molecular mechanisms in oncogenesis, tumor progression, and therapy resistance","volume":"13","author":"Kaleem","year":"2025","journal-title":"Naunyn-Schmiedeberg\u2019s Arch Pharmacol"},{"key":"B58","doi-asserted-by":"publisher","first-page":"287","DOI":"10.31083\/j.fbl2908287","article-title":"Epigenetic modulations in breast cancer: an emerging paradigm in therapeutic implications","volume":"29","author":"Sarkar","year":"2024","journal-title":"Front Bioscience-Landmark"},{"key":"B59","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.3390\/cancers13061333","article-title":"Epigenetic regulation of MicroRNA clusters and families during tumor development","volume":"13","author":"Gregorova","year":"2021","journal-title":"Cancers"},{"key":"B60","doi-asserted-by":"publisher","first-page":"1578","DOI":"10.3390\/cells12121578","article-title":"A comprehensive review of miRNAs and their epigenetic effects in glioblastoma","volume":"12","author":"Hasan","year":"2023","journal-title":"Cells"},{"key":"B61","doi-asserted-by":"publisher","first-page":"1590","DOI":"10.3390\/biom13111590","article-title":"Microrna-mediated regulation of histone-modifying enzymes in cancer: mechanisms and therapeutic implications","volume":"13","author":"Szczepanek","year":"2023","journal-title":"Biomolecules"},{"key":"B62","doi-asserted-by":"publisher","DOI":"10.1038\/onc.2009.19","article-title":"miR-449a targets HDAC-1 and induces growth arrest in prostate cancer","volume":"28","author":"Noonan","year":"2009","journal-title":"Oncogene"},{"key":"B63","doi-asserted-by":"publisher","DOI":"10.1038\/s41573-023-00704-7","article-title":"Amplifying gene expression with RNA-targeted therapeutics","volume":"22","author":"Khorkova","year":"2023","journal-title":"Nat Rev Drug Discov"},{"key":"B64","doi-asserted-by":"publisher","first-page":"11502","DOI":"10.3390\/ijms231911502","article-title":"miRNA: A promising therapeutic target in cancer","volume":"23","author":"Menon","year":"2022","journal-title":"Int J Mol Sci"},{"key":"B65","doi-asserted-by":"publisher","DOI":"10.1158\/1535-7163.MCT-15-0985","article-title":"Therapeutic targeting of miR-29b\/HDAC4 epigenetic loop in multiple myeloma","volume":"15","author":"Amodio","year":"2016","journal-title":"Mol Cancer Ther"},{"key":"B66","doi-asserted-by":"publisher","DOI":"10.18632\/aging.103427","article-title":"LncRNA NEAT1\/miR-129\/Bcl-2 signaling axis contributes to HDAC inhibitor tolerance in nasopharyngeal cancer","volume":"12","author":"Xue","year":"2020","journal-title":"Aging"},{"key":"B67","doi-asserted-by":"publisher","first-page":"13453","DOI":"10.3390\/ijms222413453","article-title":"Influence of benzo (a) pyrene on different epigenetic processes","volume":"22","author":"Bukowska","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B68","doi-asserted-by":"publisher","first-page":"5657","DOI":"10.1038\/s41467-019-13527-1","article-title":"DNA methylation directs microRNA biogenesis in mammalian cells","volume":"10","author":"Glaich","year":"2019","journal-title":"Nat Commun"},{"key":"B69","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-07-2544","article-title":"Hypermethylation of let-7a-3 in epithelial ovarian cancer is associated with low insulin-like growth factor-II expression and favorable prognosis","volume":"67","author":"Lu","year":"2007","journal-title":"Cancer Res"},{"key":"B70","doi-asserted-by":"publisher","DOI":"10.1111\/jcmm.2018.22.issue-10","article-title":"Retracted: epigenetic silenced miR-125a-5p could be self-activated through targeting Suv39H1 in gastric cancer","volume":"22","author":"Cai","year":"2018","journal-title":"J Cell Mol Med"},{"key":"B71","doi-asserted-by":"publisher","DOI":"10.3892\/ijmm.2018.3464","article-title":"Methylation-induced downregulation and tumor-suppressive role of microRNA-98 in glioma through targeting Sal-like protein 4","volume":"41","author":"Xia","year":"2018","journal-title":"Int J Mol Med"},{"key":"B72","doi-asserted-by":"publisher","DOI":"10.1002\/2211-5463.12799","article-title":"Retracted: Demethylation of miR-195 suppresses prostate cancer cell proliferation, migration and invasion","volume":"10","author":"Ma","year":"2020","journal-title":"FEBS Open bio"},{"key":"B73","doi-asserted-by":"publisher","first-page":"497","DOI":"10.3892\/or.2017.5698","article-title":"MicroRNA-497 acts as a tumor suppressor in gastric cancer and is downregulated by DNA methylation","volume":"38","author":"Liu","year":"2017","journal-title":"Oncol Rep"},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.624725","article-title":"Tumor immune microenvironment and its related miRNAs in tumor progression","volume":"12","author":"Xing","year":"2021","journal-title":"Front Immunol"},{"key":"B75","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1038\/s41389-018-0106-y","article-title":"miR-100 maintains phenotype of tumor-associated macrophages by targeting mTOR to promote tumor metastasis via Stat5a\/IL-1ra pathway in mouse breast cancer","volume":"7","author":"Wang","year":"2018","journal-title":"Oncogenesis"},{"key":"B76","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1038\/s41467-019-08989-2","article-title":"Apoptotic tumor cell-derived microRNA-375 uses CD36 to alter the tumor-associated macrophage phenotype","volume":"10","author":"Frank","year":"2019","journal-title":"Nat Commun"},{"key":"B77","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1700167","article-title":"Regulated polarization of tumor-associated macrophages by mir-145 via colorectal cancer\u2013derived extracellular vesicles","volume":"199","author":"Shinohara","year":"2017","journal-title":"J Immunol"},{"key":"B78","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/s41467-018-03224-w","article-title":"Mutant p53 cancers reprogram macrophages to tumor supporting macrophages via exosomal miR-1246","volume":"9","author":"Cooks","year":"2018","journal-title":"Nat Commun"},{"key":"B79","doi-asserted-by":"publisher","DOI":"10.1074\/jbc.M111.327031","article-title":"Identifying functional microRNAs in macrophages with polarized phenotypes","volume":"287","author":"Graff","year":"2012","journal-title":"J Biol Chem"},{"key":"B80","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2014.00614","article-title":"Molecular mechanisms that influence the macrophage M1\u2013M2 polarization balance","volume":"5","author":"Wang","year":"2014","journal-title":"Front Immunol"},{"key":"B81","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2010.02.002","article-title":"MicroRNAs in immune regulation\u2014opportunities for cancer immunotherapy","volume":"42","author":"Okada","year":"2010","journal-title":"Int J Biochem Cell Biol"},{"key":"B82","doi-asserted-by":"publisher","DOI":"10.1021\/acs.nanolett.8b00689","article-title":"Repolarization of tumor-associated macrophages in a genetically engineered nonsmall cell lung cancer model by intraperitoneal administration of hyaluronic acid-based nanoparticles encapsulating microRNA-125b","volume":"18","author":"Parayath","year":"2018","journal-title":"Nano Lett"},{"key":"B83","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1556064","article-title":"RETRACTED ARTICLE: TGF-\u03b2 secreted by tumor-associated macrophages promotes proliferation and invasion of colorectal cancer via miR-34a-VEGF axis","volume":"17","author":"Zhang","year":"2018","journal-title":"Cell Cycle"},{"key":"B84","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.biochi.2018.04.016","article-title":"MiR-98 suppresses the effects of tumor-associated macrophages on promoting migration and invasion of hepatocellular carcinoma cells by regulating IL-10","volume":"150","author":"Li","year":"2018","journal-title":"Biochimie"},{"key":"B85","doi-asserted-by":"publisher","first-page":"e77890","DOI":"10.1371\/journal.pone.0077890","article-title":"MicroRNA-17, 20a regulates the proangiogenic function of tumor-associated macrophages via targeting hypoxia-inducible factor 2\u03b1","volume":"8","author":"Xu","year":"2013","journal-title":"PloS One"},{"key":"B86","doi-asserted-by":"publisher","DOI":"10.1111\/febs.v286.18","article-title":"Immunomodulatory MicroRNAs in cancer: targeting immune checkpoints and the tumor microenvironment","volume":"286","author":"Omar","year":"2019","journal-title":"FEBS J"},{"key":"B87","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s40779-024-00586-9","article-title":"Role of PD-1\/PD-L1 signaling axis in oncogenesis and its targeting by bioactive natural compounds for cancer immunotherapy","volume":"11","author":"Godiyal","year":"2024","journal-title":"Military Med Res"},{"key":"B88","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1186\/s12935-024-03293-6","article-title":"MicroRNAs as regulators of immune checkpoints in cancer immunotherapy: targeting PD-1\/PD-L1 and CTLA-4 pathways","volume":"24","author":"Zabeti Touchaei","year":"2024","journal-title":"Cancer Cell Int"},{"key":"B89","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.cytogfr.2017.07.001","article-title":"Immune modulatory microRNAs as a novel mechanism to revert immune escape of tumors","volume":"36","author":"Seliger","year":"2017","journal-title":"Cytokine Growth factor Rev"},{"key":"B90","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2017.11.120","article-title":"Biochemical and Biophysical Research Communications MicroRNA-140 suppresses osteosarcoma tumor growth by enhancing anti-tumor immune response and blocking mTOR signaling","volume":"495","author":"Ji","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"B91","doi-asserted-by":"publisher","DOI":"10.1016\/j.omto.2022.03.010","article-title":"miR-15a and miR-15b modulate natural killer and CD8+ T-cell activation and anti-tumor immune response by targeting PD-L1 in neuroblastoma","volume":"25","author":"Pathania","year":"2022","journal-title":"Mol Therapy-Oncolytics"},{"key":"B92","doi-asserted-by":"publisher","first-page":"6145","DOI":"10.3390\/cancers13236145","article-title":"miRNAs in the regulation of cancer immune response: effect of miRNAs on cancer immunotherapy","volume":"13","author":"Pottoo","year":"2021","journal-title":"Cancers"},{"key":"B93","doi-asserted-by":"publisher","first-page":"5938688","DOI":"10.1155\/2022\/5938688","article-title":"Anti-PD-L1 antibody enhances T cell immune responses and reduces resistance of breast cancer cells to radiotherapy","volume":"2022","author":"Guo","year":"2022","journal-title":"Oxid Med Cell Longevity"},{"key":"B94","doi-asserted-by":"publisher","first-page":"2875","DOI":"10.1158\/1538-7445.AM2015-2875","article-title":"p53 regulation of PDL1 is mediated through miR-34a","volume":"75","author":"Cortez","year":"2015","journal-title":"Cancer Res"},{"key":"B95","doi-asserted-by":"publisher","first-page":"53735","DOI":"10.18632\/oncotarget.10731","article-title":"miR-28 modulates exhaustive differentiation of T cells through silencing programmed cell death-1 and regulating cytokine secretion","volume":"7","author":"Li","year":"2016","journal-title":"Oncotarget"},{"key":"B96","doi-asserted-by":"publisher","first-page":"e132334","DOI":"10.1172\/jci.insight.132334","article-title":"MicroRNA-146a regulates immune-related adverse events caused by immune checkpoint inhibitors","volume":"5","author":"Marschner","year":"2020","journal-title":"JCI Insight"},{"key":"B97","doi-asserted-by":"publisher","first-page":"113850","DOI":"10.1016\/j.intimp.2024.113850","article-title":"Identification and validation of an immune-related miRNA signature for predicting prognosis of hepatocellular carcinoma","volume":"146","author":"Hu","year":"2025","journal-title":"Int Immunopharmacology"},{"key":"B98","doi-asserted-by":"publisher","first-page":"106683","DOI":"10.1016\/j.jsbmb.2025.106683","article-title":"Characterization of novel sialylation-associated microRNA signature for prognostic assessment in breast cancer and its implications for the tumor microenvironment","volume":"13","author":"Chen","year":"2025","journal-title":"J Steroid Biochem Mol Biol"},{"key":"B99","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2024.1397945","article-title":"Understanding the role of miRNAs in cervical cancer pathogenesis and therapeutic responses","volume":"12","author":"Chauhan","year":"2024","journal-title":"Front Cell Dev Biol"},{"key":"B100","doi-asserted-by":"publisher","first-page":"1469","DOI":"10.3390\/ijms25031469","article-title":"Trials and tribulations of MicroRNA therapeutics","volume":"25","author":"Seyhan","year":"2024","journal-title":"Int J Mol Sci"},{"key":"B101","doi-asserted-by":"publisher","DOI":"10.1038\/s12276-023-01050-9","article-title":"MicroRNA: trends in clinical trials of cancer diagnosis and therapy strategies","volume":"55","author":"Kim","year":"2023","journal-title":"Exp Mol Med"},{"key":"B102","article-title":"The fundamental role of miR-10b in metastatic cancer","volume":"8","author":"Sheedy","year":"2018","journal-title":"Am J Cancer Res"},{"key":"B103","article-title":"MiRNA-210: a current overview","volume":"37","author":"Bavelloni","year":"2017","journal-title":"Anticancer Res"},{"key":"B104","first-page":"2017","article-title":"Multiple myeloma-derived exosomes regulate the functions of mesenchymal stem cells partially via modulating miR-21 and miR-146a","volume":"2017","author":"Cheng","year":"2025","journal-title":"Stem Cells Int"},{"key":"B105","doi-asserted-by":"publisher","first-page":"871","DOI":"10.3390\/biom13050871","article-title":"Circulating microRNAs for early diagnosis of ovarian cancer: A systematic review and meta-analysis","volume":"13","author":"Frisk","year":"2023","journal-title":"Biomolecules"},{"key":"B106","doi-asserted-by":"publisher","DOI":"10.3389\/fgene.2021.690598","article-title":"Immune-related nine-MicroRNA signature for predicting the prognosis of gastric cancer","volume":"12","author":"Xu","year":"2021","journal-title":"Front Genet"},{"key":"B107","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S346790","article-title":"A six-microRNA signature nomogram for preoperative prediction of tumor deposits in colorectal cancer","volume":"18","author":"Xiao","year":"2022","journal-title":"Int J Gen Med"},{"key":"B108","unstructured":"Pancreatic cancer statistics | Cancer Research UK.\u201d"},{"key":"B109","doi-asserted-by":"publisher","DOI":"10.1038\/ncb3169","article-title":"Pancreatic cancer exosomes initiate pre-metastatic niche formation in the liver","volume":"17","author":"Costa-Silva","year":"2015","journal-title":"Nat Cell Biol"},{"key":"B110","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v7i19","article-title":"Prospective validation of microRNA signatures for detecting pancreatic Malignant transformation in endoscopic-ultrasound guided fine-needle aspiration biopsies","volume":"7","author":"Frampton","year":"2016","journal-title":"Oncotarget"},{"key":"B111","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2012.10.012","article-title":"Metastatic colonization requires the repression of the epithelial-mesenchymal transition Prrx1","volume":"22","author":"Oca\u00f1a","year":"2012","journal-title":"Cancer Cell"},{"key":"B112","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2005.03.151","article-title":"Mdmx as an essential regulator of p53 activity","volume":"331","author":"Marine","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"B113","doi-asserted-by":"publisher","DOI":"10.3322\/caac.21601","article-title":"Colorectal cancer statistics, 2020","volume":"70","author":"Siegel","year":"2020","journal-title":"CA: Cancer J Clin"},{"key":"B114","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20180790","article-title":"LINC00473 promotes the Taxol resistance via miR-15a in colorectal cancer","volume":"38","author":"Wang","year":"2018","journal-title":"Bioscience Rep"},{"key":"B115","doi-asserted-by":"publisher","DOI":"10.3892\/etm.2019.7650","article-title":"Long non\u2212coding RNA SNHG12 promotes proliferation and invasion of colorectal cancer cells by acting as a molecular sponge of microRNA\u221216","volume":"18","author":"Liu","year":"2019","journal-title":"Exp Ther Med"},{"key":"B116","doi-asserted-by":"publisher","DOI":"10.1042\/CBI20110404","article-title":"Vector-based miR-15a\/16-1 plasmid inhibits colon cancer growth in vivo","volume":"36","author":"Dai","year":"2012","journal-title":"Cell Biol Int"},{"key":"B117","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2018.06.025","article-title":"Tumour suppressor properties of miR-15a and its regulatory effects on BCL2 and SOX2 proteins in colorectal carcinomas","volume":"370","author":"Gopalan","year":"2018","journal-title":"Exp Cell Res"},{"key":"B118","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-13-2203","article-title":"p53-Induced miR-15a\/16-1 and AP4 Form a Double-Negative Feedback Loop to Regulate Epithelial\u2013Mesenchymal Transition and Metastasis in Colorectal CancerReciprocal Regulation of miR-15a\/16-1 and AP4","volume":"74","author":"Shi","year":"2014","journal-title":"Cancer Res"},{"key":"B119","doi-asserted-by":"publisher","first-page":"2367","DOI":"10.18632\/oncotarget.23414","article-title":"Modified miR-15a has therapeutic potential for improving treatment of advanced stage colorectal cancer through inhibition of BCL2, BMI1, YAP1 and DCLK1","volume":"9","author":"Fesler","year":"2018","journal-title":"Oncotarget"},{"key":"B120","doi-asserted-by":"publisher","first-page":"18837","DOI":"10.18632\/oncotarget.v7i14","article-title":"High blood sugar levels significantly impact the prognosis of colorectal cancer patients through down-regulation of microRNA-16 by targeting Myb and VEGFR2","volume":"7","author":"Yang","year":"2016","journal-title":"Oncotarget"},{"key":"B121","doi-asserted-by":"publisher","first-page":"10311","DOI":"10.2147\/OTT.S190998","article-title":"Influence and mechanism of miR-99a suppressing development of colorectal cancer (CRC) with diabetes mellitus (DM)","volume":"12","author":"Zhu","year":"2019","journal-title":"OncoTargets Ther"},{"key":"B122","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2015.07.036","article-title":"miR-125a-5p inhibits cell proliferation and induces apoptosis in colon cancer via targeting BCL2, BCL2L12 and MCL1","volume":"75","author":"Tong","year":"2015","journal-title":"Biomedicine pharmacotherapy"},{"key":"B123","doi-asserted-by":"publisher","first-page":"5839","DOI":"10.2147\/CMAR.S161990","article-title":"miR-125a-5p suppresses colorectal cancer progression by targeting VEGFA","volume":"10","author":"Yang","year":"2018","journal-title":"Cancer Manage Res"},{"key":"B124","doi-asserted-by":"publisher","DOI":"10.1002\/feb4.2019.9.issue-7","article-title":"MicroRNA-125a inhibits tumorigenesis by targeting Smurf1 in colorectal carcinoma","volume":"9","author":"Li","year":"2019","journal-title":"FEBS Open Bio"},{"key":"B125","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1053\/j.gastro.2009.05.004","article-title":"Selective blockade of DCAMKL-1 results in tumor growth arrest by a Let-7a MicroRNA-dependent mechanism","volume":"137","author":"Sureban","year":"2009","journal-title":"Gastroenterology"},{"key":"B126","doi-asserted-by":"publisher","DOI":"10.1016\/j.canlet.2011.09.033","article-title":"NIRF is frequently upregulated in colorectal cancer and its oncogenicity can be suppressed by let-7a microRNA","volume":"314","author":"Wang","year":"2012","journal-title":"Cancer Lett"},{"key":"B127","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbrc.2016.08.018","article-title":"Let-7a inhibits tumor cell growth and metastasis by directly targeting RTKN in human colon cancer","volume":"478","author":"Li","year":"2016","journal-title":"Biochem Biophys Res Commun"},{"key":"B128","doi-asserted-by":"publisher","DOI":"10.1002\/path.v226.3","article-title":"Let-7c functions as a metastasis suppressor by targeting MMP11 and PBX3 in colorectal cancer","volume":"226","author":"Han","year":"2012","journal-title":"J Pathol"},{"key":"B129","doi-asserted-by":"publisher","DOI":"10.1016\/j.lfs.2019.05.005","article-title":"Induction of let-7e gene expression attenuates oncogenic phenotype in HCT-116 colorectal cancer cells through targeting of DCLK1 regulation","volume":"228","author":"Kohlan","year":"2019","journal-title":"Life Sci"},{"key":"B130","doi-asserted-by":"publisher","DOI":"10.1080\/15384101.2018.1469873","article-title":"IGF1\/IGF1R and microRNA let-7e down-regulate each other and modulate proliferation and migration of colorectal cancer cells","volume":"17","author":"Li","year":"2018","journal-title":"Cell Cycle"},{"key":"B131","doi-asserted-by":"publisher","DOI":"10.1038\/nrd.2016.246","article-title":"MicroRNA therapeutics: Towards a new era for the management of cancer and other diseases","volume":"16","author":"Rupaimoole","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"B132","doi-asserted-by":"publisher","DOI":"10.1038\/nrd4140","article-title":"MicroRNAs and other non-coding RNAs as targets for anticancer drug development","volume":"12","author":"Ling","year":"2013","journal-title":"Nat Rev Drug Discov"},{"key":"B133","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S202664","article-title":"MicroRNA-34a suppresses aggressiveness of hepatocellular carcinoma by modulating E2F1, E2F3, and Caspase-3","volume":"11","author":"Han","year":"2019","journal-title":"Cancer Manage Res"},{"key":"B134","doi-asserted-by":"publisher","first-page":"276","DOI":"10.3390\/cells9020276","article-title":"miRNAs as biomarkers in disease: latest findings regarding their role in diagnosis and prognosis","volume":"9","author":"Condrat","year":"2020","journal-title":"Cells"},{"key":"B135","doi-asserted-by":"publisher","first-page":"109428","DOI":"10.1016\/j.biopha.2019.109428","article-title":"Functions and mechanisms of miR-186 in human cancer","volume":"119","author":"Wang","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B136","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s13104-017-2950-9","article-title":"Urine cell-free microRNA as biomarkers for transitional cell carcinoma","volume":"10","author":"Geva","year":"2017","journal-title":"BMC Res notes"},{"key":"B137","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/srep15100","article-title":"An improved method for detecting circulating microRNAs with S-Poly (T) Plus real-time PCR","volume":"5","author":"Niu","year":"2015","journal-title":"Sci Rep"},{"key":"B138","doi-asserted-by":"publisher","first-page":"e38389","DOI":"10.7554\/eLife.38389.048","article-title":"Importance of miRNA stability and alternative primary miRNA isoforms in gene regulation during Drosophila development","volume":"7","author":"Zhou","year":"2018","journal-title":"Elife"},{"key":"B139","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.82738","article-title":"Therapeutic implication of miRNA in human disease","author":"Walayat","year":"2018","journal-title":"IntechOpen"},{"key":"B140","doi-asserted-by":"publisher","DOI":"10.3390\/molecules27020536","article-title":"Small drugs, huge impact: the extraordinary impact of antisense oligonucleotides in research and drug dvelopment","volume":"27","author":"Quemener","year":"2022","journal-title":"Molecules"},{"key":"B141","doi-asserted-by":"publisher","DOI":"10.1080\/15476286.2018.1445959","article-title":"Anti-miRNA oligonucleotides: A comprehensive guide for design","volume":"15","author":"Lima","year":"2018","journal-title":"RNA Biol"},{"key":"B142","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/s43094-022-00413-9","article-title":"Recent trends in miRNA therapeutics and the application of plant miRNA for prevention and treatment of human diseases","volume":"8","author":"Saiyed","year":"2022","journal-title":"Futur J Pharm Sci"},{"key":"B143","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.v12i17","article-title":"Role of microRNAs in glioblastoma","volume":"12","author":"Chen","year":"2021","journal-title":"Oncotarget"},{"key":"B144","doi-asserted-by":"publisher","DOI":"10.1038\/nrd3179","article-title":"Targeting microRNAs in cancer: rationale, strategies and challenges","volume":"9","author":"Garzon","year":"2010","journal-title":"Nat Rev Drug Discov"},{"key":"B145","article-title":"The principles of MiRNA-masking antisense oligonucleotides technology","volume":"676","author":"Wang","year":"2011","journal-title":"Methods Mol Biol"},{"key":"B146","doi-asserted-by":"publisher","first-page":"110546","DOI":"10.1016\/j.biopha.2020.110546","article-title":"Targeting miRNAs by natural products: A new way for cancer therapy","volume":"130","author":"Zhang","year":"2020","journal-title":"BioMed Pharmacother"},{"key":"B147","doi-asserted-by":"publisher","DOI":"10.1080\/17460441.2020.1765770","article-title":"Challenges identifying efficacious miRNA therapeutics for cancer","volume":"15","author":"Segal","year":"2020","journal-title":"Expert Opin Drug Discov"},{"key":"B148","doi-asserted-by":"publisher","first-page":"e0224396","DOI":"10.1371\/journal.pone.0224396","article-title":"Expression of miR-34a-5p is up-regulated in human colorectal cancer and correlates with survival and clock gene PER2 expression","volume":"14","author":"Hasakova","year":"2019","journal-title":"PloS One"},{"key":"B149","doi-asserted-by":"publisher","first-page":"35:101519","DOI":"10.1016\/j.bbrep.2023.101519","article-title":"MicroRNA targeting: A novel therapeutic intervention for ovarian cancer","author":"Asl","year":"2023","journal-title":"Biochem Biophysics Rep"},{"key":"B150","doi-asserted-by":"publisher","DOI":"10.3892\/ol.2017.6501","article-title":"microRNA-494 is a potential prognostic marker and inhibits cellular proliferation, migration and invasion by targeting SIRT1 in epithelial ovarian cancer","volume":"14","author":"Yang","year":"2017","journal-title":"Oncol Lett"},{"key":"B151","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)31715-9","article-title":"Safety, tolerability, and antiviral effect of RG-101 in patients with chronic hepatitis C: a phase 1B, double-blind, randomized controlled trial","volume":"389","author":"van der Ree","year":"2017","journal-title":"Lancet"},{"key":"B152","article-title":"Altering the biological functions of microRNAs by the miRNA-masking approach as a possible therapeutic strategy for rare diseases","author":"Sultan","year":"2021"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570093\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T04:10:22Z","timestamp":1753071022000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2025.1570093\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,7,21]]},"references-count":152,"alternative-id":["10.3389\/fonc.2025.1570093"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2025.1570093","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,7,21]]},"article-number":"1570093"}}